openPR Logo
Press release

Osteoporosis Treatment Market Trends, Outlook And Industry Demand 2024-2033

12-07-2024 10:39 AM CET | Health & Medicine

Press release from: The Business research company

Osteoporosis Treatment Market Trends

Osteoporosis Treatment Market Trends

The Business Research Company recently released a comprehensive report on the Global Osteoporosis Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=12166&type=smp

According to The Business Research Company's, The osteoporosis treatment market size has grown strongly in recent years. It will grow from $13.16 billion in 2023 to $13.87 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to aging population demographics, hormone replacement therapies, calcium and vitamin d supplementation, increased diagnostic tools, integration of digital health solutions.

The osteoporosis treatment market size is expected to see steady growth in the next few years. It will grow to $16.6 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to rise in sedentary lifestyles, rising prevalence of secondary osteoporosis, virtual bone fracture clinics, gene therapy for osteoporosis, increased focus on men's bone health. Major trends in the forecast period include advancements in biologics, integration of artificial intelligence, blockchain in bone health records, integration of machine learning.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/osteoporosis-treatment-global-market-report

Market Drivers and Trends:

The increasing prevalence and incidence of osteoporosis are expected to propel the growth of the osteoporosis treatment market going forward. Osteoporosis is a bone disease that manifests when bone strength and composition change or when bone mass and mineral density drop. Most osteoporosis drugs function by slowing down the rate at which your bones deteriorate. At the same time, hormone-based treatments such as estrogen can help maintain bone density, especially when taken immediately after menopause. For instance, in May 2022, according to Amgen, a US-based biopharmaceutical company, the annual number of fractures due to osteoporosis is expected to increase by 68% to 3.2 million by 2040. Therefore, the increasing prevalence and incidence of osteoporosis are driving the growth of the osteoporosis treatment market.

Product innovation is a key trend gaining popularity in the osteoporosis treatment market. Major companies operating in the osteoporosis treatment market are adopting recent technologies to sustain their position in the market. For instance, in January 2021, Theramex, a UK-based pharmaceutical company, launched Livogiva, a new teriparatide pre-filled pen for treating severe osteoporosis. Livogiva is a biosimilar of the Forsteo reference drug teriparatide, and in phase III clinical investigation, individuals with severe osteoporosis who received treatment for six months showed therapeutic equivalence.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:

Pfizer Inc., F. Hoffmann La Roche Ltd., Merck and Co Inc., AbbVie Inc., Novartis AG, GlaxoSmithKline Pharmaceutical Ltd., Takeda Pharmaceutical Company, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Asahi Kasei Corporation, AstraZeneca Plc., Viatris Inc., Allergan plc, Teva Pharmaceuticals Industries Ltd., Biogen Inc., Daiichi Sankyo company Ltd, Dr. Reddy's Laboratories, Gedeon Richter Plc., Celltrion Inc., Luye Pharma Group, Covis Pharmaceuticals Inc., Ligand Pharmaceuticals Incorporated, Radius Health Inc., Haoma Medica Ltd., Actavis plc, EffRx Pharmaceuticals SA

Osteoporosis Treatment Market 2024 Key Insights:

• The osteoporosis treatment market size is expected to see steady growth in the next few years. It will grow to $16.6 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%.
• Rising Prevalence Of Osteoporosis Fuels Growth In Osteoporosis Treatment Market
• Innovative Solutions Transform Osteoporosis Treatment Market
• North America was the largest region in the osteoporosis treatment market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=12166&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Osteoporosis Treatment Market Trends, Outlook And Industry Demand 2024-2033 here

News-ID: 3777108 • Views:

More Releases from The Business research company

Unlocking Opportunities in the Wound Debridement Market: 2025-2034 Forecast Report
Unlocking Opportunities in the Wound Debridement Market: 2025-2034 Forecast Repo …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Wound Debridement Industry Market Size Be by 2025? The market for wound debridement has seen robust growth in the past few years. The market size is projected to enhance from $5.21 billion in 2024 to $5.49 billion in 2025, with a compound annual growth rate (CAGR)
Transformative Trends Impacting the Sterilization Equipment Market Landscape: Sterile Container System To Streamline Sterilization Processes
Transformative Trends Impacting the Sterilization Equipment Market Landscape: St …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Sterilization Equipment Market Size By 2025? The market size for sterilization equipment has witnessed robust growth recently. The market is expected to expand from a value of $13.25 billion in 2024 to $14.56 billion in 2025, with a compound annual growth rate (CAGR) of 9.9%.
Rising Demand For Personalized Medicine Drives Rna Analysis Market Growth: Pivotal Factor Influencing RNA Analysis/ Transcriptomics Market Growth in 2025
Rising Demand For Personalized Medicine Drives Rna Analysis Market Growth: Pivot …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. RNA Analysis/ Transcriptomics Market Size Growth Forecast: What to Expect by 2025? In recent times, there has been a notable expansion in the size of the rna analysis/ transcriptomics market. This market is projected to increase from $7.72 billion in 2024 to $8.74 billion the following year, with a
Orthopedic Regenerative Surgical Products Market Expansion Continues, with Forecast Valuation of $6.84 Billion by 2029
Orthopedic Regenerative Surgical Products Market Expansion Continues, with Forec …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Orthopedic Regenerative Surgical Products Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for orthopedic regenerative surgical products has seen robust growth in the past few years. The market, which was valued at $4.54 billion in 2024, is projected to grow to $4.88

All 5 Releases


More Releases for Osteoporosis

Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: …
The Osteoporosis Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period? The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate? The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss. View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of
Osteoporosis Drugs: The Complete Review
Medication for osteoporosis increases bone mineral density and reduces fracture risk. Some osteoporosis medications promote bone growth while others reduce bone loss. The bones may begin to deteriorate as age more quickly than the body can heal them. The doctor could determine that people have osteoporosis if they have significant bone density loss. To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market/report-sample Although osteoporosis cannot be treated, it can be slowed down or
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related